✦ LIBER ✦

Phase II of doxorubicin/taxol in metastatic breast cancer

✍ Scribed by Claudia Pazos; Elizabeth Mickiewicz; María Rosa Di Notto; Federico Cóppola; Mónica Ventriglia; Silvia Jovtis; Luis Balbiani; Daniel Lewi; Mónica Róndinón; Guillermo Témperley; Mariana Trigo; Ana María Bertoncín; María Pascual; Graciela Uranga; Eduardo Cazap; Simónla Breier; Sergio Grasso; Roberto Estévez; Eduardo Triguboff; Ana Alvarez; Albertoi Suárez

Book ID: 110232982
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 60 KB
Volume: 55
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1006194909859

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of doxorubicin and triflu

Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer

✍ G. T. Budd; R. M. Bukowski; A. Lichtin; L. Bauer; P. Kirk; R. Ganapathi 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 361 KB

Typhlitis resulting from treatment with

Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer

✍ Bernhard C. Pestalozzi; George A. Sotos; Peter L. Choyke; Jason S. Fisherman; Ke 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

## Background. Typhlitis is being recognized with in- creasing frequency as a serious complication of aggressive chemotherapy for hematologic and solid malignancies. In this report the authors describe two cases of typhlitis in patients with metastatic breast cancer treated with taxol and doxorub

`Abraxane' vs `Taxol' in metastatic brea

`Abraxane' vs `Taxol' in metastatic breast cancer

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

First line therapy with paclitaxel (Taxo

First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study

✍ D.A Vorobiof; B.L Rapoport; M.R Chasen; C Slabber; G McMichael; R Eek; C Mohamme 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Evaluation of Taxol Cardiotoxicity in Me

Evaluation of Taxol Cardiotoxicity in Metastatic Breast Cancer

✍ O. BIADI; G. MENGOZZI; G. GHERARDUCCI; G. STRATA; M. MARIANI; F. BALDINI; P. G. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Phase I study of taxol plus doxorubicin

Phase I study of taxol plus doxorubicin plus granulocyte colony-stimulating factor (G-CSF) in patients with metastatic breast cancer

✍ O'Shaughnessy, JA; Fisherman, J; McCabe, M; Noone, M; Cowan, KH 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 173 KB